Overview
Andrew Lerner, M.D., is a clinical instructor of medicine in the pulmonary and critical care medicine department at the Johns Hopkins University School of Medicine, as well as the director of interventional pulmonology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. He practices out of Sibley Memorial Hospital in Washington, D.C. Dr. Lerner is part of the Sibley Memorial Hospital Lung Nodule and Lung Cancer Screening Clinic, the Multidisciplinary Pulmonary and Thoracic Surgery Clinic, and the Multidisciplinary Thoracic Tumor Board Conference. Dr. Lerner has an expertise in minimally invasive procedures for the early diagnosis and treatment of malignant and non-malignant diseases of the airways, lungs and pleura. He is experienced in advanced diagnostic and therapeutic bronchoscopy, including endobronchial ultrasound (EBUS) bronchoscopy, navigational bronchoscopy, rigid bronchoscopy, tumor ablative techniques, airway stent placement, airway dilation, radial EBUS, conventional transbronchial needle aspiration (TBNA), bronchial thermoplasty, whole lung lavage and percutaneous lung biopsy; as well as percutaneous tracheostomy, tunneled pleural catheter placement, thoracentesis, tube thoracoscopy, medical thoracoscopy, chemical pleurodesis and upper endoscopy (EGD/PEG) placement. Dr. Lerner earned his medical degree from George Washington University School of Medicine. He completed his residency in internal medicine at Thomas Jefferson University Hospital, followed by a fellowship in pulmonary and critical care medicine at the University of California, San Diego. Dr. Lerner then completed a two-year advanced fellowship in interventional pulmonology at The Johns Hopkins Hospital, including a chief fellowship year. He has been involved in multiple research projects in the field and completed a Science of Clinical Investigation Certificate Program at Johns Hopkins University Bloomberg School of Public Health. Dr. Lerner has been a member of the Alpha Omega Alpha medical honors society since 2011 and earned The Johns Hopkins Hospital Patient Safety Star Award in 2016. Dr. Lerner has contributed to numerous presentations, lectures, publications, book chapters and abstracts. He is a reviewer for several research journals. Dr. Lerner has various research interests and is currently involved in research projects focusing on EBUS bronchoscopy, lung cancer diagnosis and staging, and other topics. Confidential email to reach Dr. Lerner for any questions: alerner@jhu.edu.
Dr. Lerner is rated as an Experienced provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Lung Nodules, Lymphofollicular Hyperplasia, Pleurisy, and Pleural Effusion.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
Locations
5215 Loughboro Road Northwest, Suite 420, Suite 420, Washington, DC 20016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins University
David Moller is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Moller is rated as a Distinguished provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Interstitial Lung Disease, and Acute Interstitial Pneumonia.
Inova Health Care Services
Steven Nathan is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Falls Church, Virginia. Dr. Nathan is rated as an Elite provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Prostatectomy. Dr. Nathan is currently accepting new patients.
Johns Hopkins Bayview Medical Center
Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is rated as a Distinguished provider by MediFind in the treatment of Sarcoidosis. His top areas of expertise are Pulmonary Hypertension, Sarcoidosis, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Lung Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung NodulesDr. Lerner isDistinguished. Learn about Lung Nodules.
- Lymphofollicular HyperplasiaDr. Lerner isDistinguished. Learn about Lymphofollicular Hyperplasia.
- Pleural EffusionDr. Lerner isDistinguished. Learn about Pleural Effusion.
- PleurisyDr. Lerner isDistinguished. Learn about Pleurisy.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Bronchogenic CystDr. Lerner isAdvanced. Learn about Bronchogenic Cyst.
- EGFR Positive Lung CancerDr. Lerner isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Lerner isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Lerner isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Lerner isAdvanced. Learn about Lung Cancer.
- Experienced
- Acquired TracheomalaciaDr. Lerner isExperienced. Learn about Acquired Tracheomalacia.
- Acute Interstitial PneumoniaDr. Lerner isExperienced. Learn about Acute Interstitial Pneumonia.
- Atypical PneumoniaDr. Lerner isExperienced. Learn about Atypical Pneumonia.
- BronchiectasisDr. Lerner isExperienced. Learn about Bronchiectasis.
- Cerebral HypoxiaDr. Lerner isExperienced. Learn about Cerebral Hypoxia.
- Chronic CoughDr. Lerner isExperienced. Learn about Chronic Cough.